Organometallics
Article
3
3
d6) δ 0.73 (6H, t, JHH = 7.5 Hz), 0.97 (6H, t, JHH = 7.5 Hz) (4 ×
CH2CH3), 2.12 (6H, s, 4′,4″-CH3), 2.11 (4H, q, 3JHH = 7.5 Hz), 2.35
MHz, CDCl3) δ 11.7 (7,18-Me), 16.5 (12,13-CH2CH3), 17.6 (8,17-
CH2CH3), 20.16, 20.21 (4 × CH2CH3), 45.3 (N-Me), 98.9 (10,15-
CH), 109.6 (5,20-CH), 118.8 (21,31-CH), 126.0 (22,32-CH), 133.8,
135.1, 136.3, 138.9, 140.7, 142.7, 145.6, 149.8; HR-MS (ESI) m/z
calcd for C36H37N3Pd 617.2022; found 617.2044.
3
(4H, q, JHH = 7.5 Hz) (4 × CH2CH3), 2.99 (3H, s, N-Me), 3.81
(4H, s, 2 × bridge-CH2), 10.14 (2H, br s, 2 × NH), 11.53 (2H, v br, 2
× CO2H); 13C NMR (125 MHz, CDCl3) δ 9.9 (4′,4′′-Me), 14.8,
16.3, 16.5, 17.2, 21.6 (2 × bridge-CH2), 30.1 (N-Me), 116.5, 119.6,
122.6, 123.1, 125.5, 130.4, 162.1 (2 × CO); HR-MS (ESI) m/z
calcd for C27H37N3O4 490.2682; found 490.2672.
[8,12,13,17-Tetraethyl-7,18,21-trimethylbenzo[b]-
carbaporphyrinato]palladium(II) (15a). Palladium(II) acetate (10
mg, 0.0450 mmol) was added to a solution of 23-methylbenzocarba-
porphyrin 16 (10 mg, 0.0195 mmol) in acetonitrile (10 mL) and the
mixture refluxed overnight. The solvent was removed under reduced
pressure and the residue chromatographed on a silica gel column
eluting with dichloromethane/hexanes (70:30). A brown band was
collected and the solvent removed under reduced pressure to give 15a
(10.2 mg, 0.0165 mmol, 85%) as a dark brown solid: mp >300 °C; 1H
NMR (500 MHz, CDCl3) δ −3.21 (3H, s, 21-CH3), 1.74 (6H, t, 3JHH
= 7.7 Hz), 1.75 (6H, t, 3JHH = 7.7 Hz) (4 × CH2CH3), 3.33 (6H, s),
3.71−3.78 (8H, m, 4 × CH2CH3), 8.22−8.25 (2H, m, 22,32-H),
9.39−9.43 (2H, m, 21,31-H), 9.56 (2H, s, 10,15-H), 10.27 (2H, s,
5,20-H). The sample had identical spectroscopic properties to a
previously prepared sample obtained by reacting 12a with Pd-
(OAc)2.21
8,12,13,17-Tetraethyl-7,18,23-trimethylbenzo[b]-
carbaporphyrin (16). N-Methyl tripyrrane dicarboxylic acid 20b
(0.144 g, 0.308 mmol) was dissolved in TFA (1.5 mL) and stirred
under nitrogen for 2 min. Dichloromethane (27 mL) was added,
followed immediately by indene dialdehyde (54.0 mg, 0.314 mmol),
and the solution was stirred under nitrogen for 2 h. The mixture was
neutralized by the dropwise addition of triethylamine; DDQ (72.0
mg, 0.317 mmol) was added, and the mixture was stirred for a further
1 h. The solution was washed with water (100 mL) and then sodium
bicarbonate (100 mL), and the solvent was removed under reduced
pressure. The residue was chromatographed twice on grade 3 neutral
alumina eluting with dichloromethane and then chloroform, and a
dark brown band was collected. The product was recrystallized from
chloroform−methanol to yield the 23-methylbenzocarbaporphyrin
(52.5 mg, 0.102 mmol, 32%) as dark purple-blue crystals: mp >300
°C; UV−vis (1% Et3N−CH2Cl2) λmax/nm (log ε) 306 (4.42), 379
(4.56), 439 (5.10), 538 (4.15), 567 (3.91), 624 (3.86), 683 (3.36);
UV−vis (1% TFA−CH2Cl2) λmax/nm (log ε) 310 (4.42), 403 (sh,
4.77), 444 (4.97), 481 (4.47), 568 (4.01), 608 (4.08), 677 (3.26); 1H
NMR (500 MHz, CDCl3) δ −4.95 (1H, s, 21-H), −4.25 (3H, s, N-
[8,12,13,17-Tetraethyl-7,18,22-trimethylbenzo[b]-
carbaporphyrinato](dicarbonyl)rhodium(I) (26). 22-Methylben-
zocarbaporphyrin 12a (10.4 mg, 0.0203 mmol) was dissolved in
dichloromethane (22 mL) under nitrogen. Anhydrous sodium acetate
(16.3 mg) was added, followed by [Rh(CO)2Cl]2 (7.8 mg, 0.0201
mmol), and the mixture was refluxed overnight under nitrogen. The
solvent was removed under reduced pressure, and the residue was
purified by column chromatography on silica gel eluting with
dichloromethane/hexanes (50:50). The rhodium complex was
collected as a brown band. Recrystallization from chloroform/hexanes
afforded 26 (6.8 mg, 0.010 mmol, 50%) as dark crystals: mp >300 °C;
UV−vis (CH2Cl2) λmax/nm (log ε) 319 (sh, 4.39), 360 (4.57), 407
(sh, 4.44), 481 (4.85), 561 (4.07), 586 (sh, 3.83), 637 (3.68); IR
(ZnSe) νCO 1985, 2057 cm−1; 1H NMR (500 MHz, CDCl3) δ −4.68
(1H, s, 21-H), −4.50 (3H, s, N-Me), 1.56 (3H, t, 3JHH = 7.7 Hz), 1.68
3
Me), −0.63 (1H, v br, NH), 1.47 (6H, t, JHH = 7.7 Hz, 12,13-
CH2CH3), 1.83 (6H, t, JHH = 7.7 Hz, 8,17-CH2CH3), 3.51 (6H, s,
3
7,18-Me), 3.67−3.75 (2H, m), 3.76−3.84 (2H, m) (12,13-CH2),
3.88−4.02 (4H, m, 8,17-CH2), 7.67−7.71 (2H, m, 22,32-H), 8.79−
8.83 (2H, m, 21,31-H), 9.67 (2H, s, 10,15-H), 10.03 (2H, s, 5,20-H);
1H NMR (500 MHz, TFA-CDCl3) δ −6.53 (1H, br s, 21-H), −4.79
3
(2H, s, 2 × NH), −4.51 (3H, s, N-Me), 1.50 (6H, t, JHH = 7.7 Hz,
3
12,13-CH2CH3), 1.77 (6H, t, JHH = 7.7 Hz, 8,17-CH2CH3), 3.60
(3H, t, 3JHH = 7.7 Hz), 1.76 (3H, t, 3JHH = 7.7 Hz), 1.79 (3H, t, 3JHH
=
(6H, s, 7,18-Me), 3.69−3.80 (4H, m, 12,13-CH2), 4.05 (4H, q, 3JHH
=
7.7 Hz, 8,17-CH2), 7.70−7.80 (2H, br, 22,32-H), 8.64−8.72 (2H, m,
21,31-H), 10.00 (2H, s, 10,15-H), 10.26 (2H, s, 5,20-H); 13C NMR
(125 MHz, CDCl3) δ 11.5 (7,18-Me), 16.9 (12,13-CH2CH3), 17.4
(8,17-CH2CH3), 20.0 (8,17-CH2), 20.1 (12,13-CH2), 31.4 (N-Me),
96.4 (10,15-CH), 103.4 (5,20-CH), 118.8 (21-CH), 120.4 (21,31-
CH), 126.5 (22,32-CH), 134.2, 135.2, 136.3, 140.7, 144.0, 147.6; 13C
NMR (125 MHz, TFA-CDCl3) δ 11.7 (7,18-Me), 16.5 (12,13-
CH2CH3), 16.9 (8,17-CH2CH3), 20.13, 20.15 (4 × CH2CH3), 30.7
(N-Me), 95.8 (10,15-CH), 103.6 (5,20-CH), 116.5 (21-CH), 121.9
(21,31-CH), 128.7 (22,32-CH), 136.2, 136.8, 138.8, 138.9, 140.6,
141.5, 141.7, 150.6; HR-MS (ESI) m/z [M + H]+ calcd for C36H40N3
514.3222; found 514.3198.
7.7 Hz) (4 × CH2CH3), 3.36 (3H, s), 3.52 (3H, s) (7,18-Me), 3.56−
3.69 (2H, m), 3.76−3.99 (6H, m) (4 × CH2CH3), 7.66−7.71 (2H, m,
22,32-H), 8.74−8.78 (2H, m, 21,31-H), 9.640 (1H, s), 9.643 (1H, s)
(10,15-H), 9.97 (1H, s), 10.16 (1H, s) (5,20-H); 13C NMR (125
MHz, CDCl3) δ 12.0, 12.3, 15.8, 17.6, 18.3, 18.4, 19.9, 20.0, 20.1,
20.6, 97.1, 102.5, 104.6, 106.6, 120.32, 120.35, 121.2 (br), 126.6,
130.1, 132.3, 132.9, 134.8, 136.5, 139.2, 139.4, 142.2, 143.7, 144.4,
1
147.8, 148.4, 149.1, 150.0, 152.5, 155.0, 178.8 (d, JRhC = 68.5 Hz,
1
CO), 179.4 (d, JRhC = 69.4 Hz, CO); HR-MS (ESI) m/z [M + H]+
calcd for C38H39N3O2Rh 672.2097; found 672.2104.
[8,12,13,17-Tetraethyl-7,18,21-trimethylbenzo[b]-
carbaporphyrinato](dicarbonyl)rhodium(I) (27). Anhydrous so-
dium acetate (11.4 mg) was added, followed by [Rh(CO)2Cl]2 (5.5
mg, 0.0142 mmol), to a solution of 21-methylbenzocarbaporphyrin
13a (7.0 mg, 0.0136 mmol) in dichloromethane (15 mL) under
nitrogen. The resulting mixture was heated under reflux overnight.
The solvent was removed under reduced pressure and the residue
purified by column chromatography on silica gel eluting with
dichloromethane/hexanes (50:50). The complex eluted as a green
band. Recrystallization from chloroform/hexanes gave the rhodium(I)
complex (6.2 mg, 0.00924 mmol, 67%) as as dark crystals: mp >300
°C; UV−vis (CH2Cl2) λmax/nm (log ε) 327 (4.18), 368 (4.34), 476
(4.56), 562 (3.71), 604 (3.71), 627 (3.64); IR (ZnSe) νCO 1996,
[8,12,13,17-Tetraethyl-7,18,23-trimethylbenzo[b]-
carbaporphyrinato]palladium(II) (22). Palladium(II) acetate
(10.0 mg, 0.0450 mmol) was added to a solution of 23-
methylbenzocarbaporphyrin 16 (10.0 mg, 0.0195 mmol) in
acetonitrile (10 mL) and heated under reflux in a preheated oil
bath for 5 min. The solution was diluted with chloroform (30 mL)
and washed with water (50 mL). The aqueous solution was back
extracted with chloroform, and the combined organic layers were
evaporated under reduced pressure. The residue was purified by
column chromatography on silica gel eluting with dichloromethane/
hexanes (70:30), and a dark green band was collected. The solvent
was removed on a rotary evaporator and the residue recrystallized
from chloroform−methanol to give the palladium complex (8.0 mg,
0.013 mmol, 67%) as dark green crystals: mp >300 °C; UV−vis
(CH2Cl2) λmax/nm (log ε) 309 (4.50), 397 (4.61), 404 (sh, 4.60), 470
(sh, 4.52), 496 (4.76), 518 (4.36), 561 (3.63), 613 (3.93), 635 (sh,
1
2063 cm−1; H NMR (500 MHz, CDCl3) δ −5.66 (3H, s, N-Me),
−2.83 (1H, br s, NH), 1.69 (3H, t, 3JHH = 7.7 Hz), 1.78−1.83 (9H, 3
overlapping triplets) (4 × CH2CH3), 3.35 (3H, s), 3.52 (3H, s) (7,18-
Me), 3.67−3.85 (3H, m), 3.88−4.01 (5H, m) (4 × CH2CH3), 7.35
4
3
4
(1H, dt, JHH = 0.9 Hz, JHH = 7.3 Hz), 7.41 (1H, dt, JHH = 0.9 Hz,
3JHH = 7.4 Hz) (22,32-H), 7.97 (1H, d, JHH = 7.2 Hz), 8.20 (1H, d,
3
1
3.90), 667 (3.84); H NMR (500 MHz, CDCl3) δ −2.86 (3H, s, N-
3JHH = 7.3 Hz) (21,31-H), 9.52 (1H, s), 9.56 (1H, s, 10,15-H), 9.69
(1H, s), 9.82 (1H, s) (5,20-H); 13C NMR (125 MHz, CDCl3) δ 11.5,
11.8 (21-Me), 12.3, 17.4, 17.6, 18.0, 18.3, 19.75, 19.84, 19.91, 20.5,
93.0, 99.9, 103.5, 108.6, 120.0, 120.2, 126.1, 126.2, 127.8, 131.5,
Me), 1.67 (6H, t, 3JHH = 7.7 Hz, 12,13-CH2CH3), 1.81 (6H, t, 3JHH
=
7.7 Hz, 8,17-CH2CH3), 3.48 (6H, s, 7,18-Me), 3.84−4.00 (8H, m, 4
× CH2CH3), 7.45−7.49 (2H, m, 22,32-H), 8.48−8.52 (2H, m, 21,31-
H), 9.85 (2H, s, 10,15-H), 10.00 (2H, s, 5,20-H); 13C NMR (125
I
Organometallics XXXX, XXX, XXX−XXX